tracheitis
Chronic bronchitis is an inflammatory change of the trachea and bronchial mucosa caused by infection or non-infectious factors, with increased mucus secretion, and clinically characterized by long-term cough, expectoration or wheezing. The early symptoms of this disease are relatively mild, mostly in winter, relieved after the spring warmth, and the course of the disease is slow, so it is not noticed by people. When the late lesions progress and obstructive emphysema is complicated, lung function is damaged, which greatly affects health and labor. This disease is one of the common and frequently-occurring diseases in my country, and the age of onset is mostly over 40 years old. Smoking patients are significantly higher than non-smoking patients. The morbidity rate in my country is higher in the north than in the south, and the incidence rate in rural areas is slightly higher than that in cities.
-
Site of disease:
trachea -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Cough sputum spitting white foamy sputum sputum is mucopurulent wet rales -
Concurrent disease:
Related Drugs
Co-sulfamethoxazole Tablets
Indication: This product is a white tablet. In recent years, many common clinical pathogens often show resistance to this product, so the treatment of bacterial infections needs to refer to the drug sensitivity results. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or Shigella sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, patients with a history of at least one attack of Pneumocystis carinii can be used.
Related Ingredients